Abstract
The management of seizures at the end of life is vital for patient comfort and to reduce carer distress. The use of high -dose subcutaneous benzodiazepines is standard, but not always effective. We present a case where lacosamide was used subcutaneously to prevent seizure activity.
Reference5 articles.
1. Clinical knowledge summary: epilepsy. NICE; 2023. Available: https://cks.nice.org.uk/topics/epilepsy/ [Accessed 15 Oct 2023].
2. Oliveira M , Lime E , et al . Factors associated with caregiver burden of adults with epilepsy in a middle-income country, Available: https://doi.org/10.1016/j.seizure.2022.03.015
3. British national Formulary 86. 2023. Available: bnf.nice.org.uk/drugs/lacosamide [Accessed 15 Oct 2023].
4. Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy;Liu;Exp Ther MED,2020
5. Subcutaneous use of lacosamide;Rémi;J Pain Symptom Manage,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献